Autologous bone marrow-derived mononuclear cell therapy in three patients with severe asthma

Autologous bone marrow-derived mononuclear cell therapy in three patients with severe asthma

Abstract Background Despite recent advances in understanding its pathophysiology and development of novel therapies, asthma remains a serious public health issue worldwide. Combination therapy with inhaled corticosteroids and long-acting β2-adrenoceptor agonists results in disease control for many p...

Full description

Bibliographic Details
Main Authors: Fabio S. Aguiar, André S. Melo, Ana Maria S. Araújo, Alexandre P. Cardoso, Sergio Augusto L. de Souza, Miquéias Lopes-Pacheco, Fernanda F. Cruz, Debora G. Xisto, Karina D. Asensi, Lanuza Faccioli, Anna Beatriz S. Salgado, Maria Carolina P. P. Landesmann, Regina C. S. Goldenberg, Bianca Gutfilen, Marcelo M. Morales, Patricia R. M. Rocco, Jose R. Lapa e Silva
Format: Article
Language:English
Published: BMC 2020-05-01
Series:Stem Cell Research & Therapy
Subjects:
Asthma
Bone marrow mononuclear cells
Cell therapy
Autologous transplantation
Lung
Online Access:http://link.springer.com/article/10.1186/s13287-020-01675-x

Internet

http://link.springer.com/article/10.1186/s13287-020-01675-x

Similar Items